# High Flow Nasal Oxygen Therapy (Optiflow™) in High-risk Cardiac Surgical Patients

> **NCT02496923** · NA · COMPLETED · sponsor: **Papworth Hospital NHS Foundation Trust** · enrollment: 100 (actual)

## Conditions studied

- Cardiac Surgery

## Interventions

- **DEVICE:** High flow nasal oxygen therapy (Optiflow™)
- **DEVICE:** Standard oxygen therapy (Hudson Type face mask or nasal prongs)

## Key facts

- **NCT ID:** NCT02496923
- **Lead sponsor:** Papworth Hospital NHS Foundation Trust
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2017-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02496923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02496923, "High Flow Nasal Oxygen Therapy (Optiflow™) in High-risk Cardiac Surgical Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02496923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*